What price per share is associated with the FRSX RSU-related Ordinary Shares?

The transaction reports a price per share of $0.0000 for the 1,000,000 Ordinary Shares. This reflects the nature of the transaction as a grant or award of equity compensation rather than an open‑market purchase for cash consideration.

Foresight Autonomous (FRSX) awards director RSUs for 1,000,000 shares

Q: What insider transaction did Foresight Autonomous (FRSX) disclose for Daniel Avidan?

Foresight Autonomous reported that director Daniel Avidan received a grant tied to 1,000,000 Ordinary Shares . These are issuable upon vesting of restricted share units (RSUs) running through January 1, 2029, with each RSU delivering one Ordinary Share.

Q: How many FRSX shares are covered by the RSU award reported in this Form 4?

The award covers 1,000,000 Ordinary Shares of Foresight Autonomous. Footnotes explain these shares are issuable upon vesting of RSUs through January 1, 2029, rather than all being immediately issued at the transaction date.

Q: What is the vesting timeline for Daniel Avidan’s FRSX RSUs?

The RSUs vest over a period ending on January 1, 2029 . The filing notes that 1,000,000 Ordinary Shares are issuable upon the vesting of these RSUs through that date, indicating a multi‑year vesting schedule rather than instant vesting.

Q: How are FRSX Ordinary Shares represented in American Depository Shares (ADSs)?

Foresight Autonomous states that its securities trade as American Depository Shares (ADSs) , where one ADS represents 90 Ordinary Shares . Each ADS is convertible at any time at the holder’s election , and the ADSs have no expiration date.

Q: Was the FRSX insider equity award made under a Rule 10b5-1 trading plan?

The disclosure indicates the Rule 10b5‑1 checkbox is not marked , so the award is not reported as made under a 10b5‑1 trading plan. The transaction is characterized instead as a grant or award of equity compensation.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Avidan Daniel reported acquisition or exercise transactions in this Form 4 filing.

Foresight Autonomous Holdings Ltd. reported that director Daniel Avidan received a grant/award tied to 1,000,000 Ordinary Shares. According to the disclosure, these shares are issuable upon the vesting of RSUs through January 1, 2029, with each RSU representing one Ordinary Share. Following this award, Avidan is shown with direct beneficial ownership of 1,000,000 underlying Ordinary Shares. The issuer’s securities trade as American Depository Shares, where one ADS represents 90 Ordinary Shares and is convertible at any time.

Insider Trade Summary

Net Buyer: 1,000,000 shares

Net Buy 1 txn

Insider Avidan Daniel

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares ^{F1, F2}	1,000,000	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 1,000,000 shares (Direct)

Footnotes (2)

F1. Includes 1,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.
F2. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.

Key Figures

RSUs awarded: 1,000,000 Ordinary Shares Transaction price per share: $0.0000 Shares following transaction: 1,000,000 Ordinary Shares +1 more

4 metrics

RSUs awarded 1,000,000 Ordinary Shares Ordinary Shares issuable upon vesting of RSUs through January 1, 2029

Transaction price per share $0.0000 Reported price per Ordinary Share in the equity grant

Shares following transaction 1,000,000 Ordinary Shares Total direct beneficial ownership of underlying Ordinary Shares after the award

ADS conversion ratio 1 ADS = 90 Ordinary Shares Ratio for issuer’s securities listed as American Depository Shares

Key Terms

restricted share units ("RSUs"), American Depository Shares ("ADS"), no par value per share

3 terms

American Depository Shares ("ADS") financial

"securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/27/2026 - 04:15 PM Accepted by SEC EDGAR 07/27/2026 - 04:15 PM

FAQ

What insider transaction did Foresight Autonomous (FRSX) disclose for Daniel Avidan?

Foresight Autonomous reported that director Daniel Avidan received a grant tied to 1,000,000 Ordinary Shares. These are issuable upon vesting of restricted share units (RSUs) running through January 1, 2029, with each RSU delivering one Ordinary Share.

How many FRSX shares are covered by the RSU award reported in this Form 4?

The award covers 1,000,000 Ordinary Shares of Foresight Autonomous. Footnotes explain these shares are issuable upon vesting of RSUs through January 1, 2029, rather than all being immediately issued at the transaction date.

What is the vesting timeline for Daniel Avidan’s FRSX RSUs?

The RSUs vest over a period ending on January 1, 2029. The filing notes that 1,000,000 Ordinary Shares are issuable upon the vesting of these RSUs through that date, indicating a multi‑year vesting schedule rather than instant vesting.

How are FRSX Ordinary Shares represented in American Depository Shares (ADSs)?

Foresight Autonomous states that its securities trade as American Depository Shares (ADSs), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time at the holder’s election, and the ADSs have no expiration date.

Was the FRSX insider equity award made under a Rule 10b5-1 trading plan?

The disclosure indicates the Rule 10b5‑1 checkbox is not marked, so the award is not reported as made under a 10b5‑1 trading plan. The transaction is characterized instead as a grant or award of equity compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Avidan Daniel

(Last)

(First)

(Middle)

C/O FORESIGHT AUTOMOMOUS

7 GOLDA MEIR ISRAEL

(Street)

NESS ZIONA

7414001

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Foresight Autonomous Holdings Ltd. [ FRSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	07/23/2026		A		1,000,000⁽¹⁾	A	$0	1,000,000⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes 1,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.

2. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.

	/s/ Daniel Avidan	07/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR